Sven Ante Lundberg

Insider Reports History

Location
C/O Crispr Therapeutics Ag, 200 Sidney Street, Cambridge, MA
Signature
/s/ Peter Silverman as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sven Ante Lundberg:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Merus N.V. President, CEO & PEO, Director Share Option (right to buy) 313K $4.23M $13.52 Apr 17, 2025 Direct
Merus N.V. President, CEO & PEO, Director Common Shares 30.3K $2.88M $95.06 Nov 25, 2025 Ante S Lundberg Qualified Annuity Interest Trust XI
Merus N.V. President, CEO & PEO, Director Common Shares 16.4K $1.56M $95.06 Nov 25, 2025 Ante S Lundberg Qualified Annuity Int Trust X
Merus N.V. President, CEO & PEO, Director Common Shares 9.19K $874K $95.06 Nov 25, 2025 Emily Lundberg 2018 Irrevocable Trust
Merus N.V. President, CEO & PEO, Director Common Shares 9.19K $874K $95.06 Nov 25, 2025 Kristian Ante Lundberg 2018 Irrevocable Trust
Merus N.V. President, CEO & PEO, Director Common Shares 9.19K $874K $95.06 Nov 25, 2025 Katrina Lundberg 2018 Irrevocable Trust
Merus N.V. President, CEO & PEO, Director Common Shares 9.19K $874K $95.06 Nov 25, 2025 Madeleine Lundberg 2018 Irrevocable Trust
Q32 Bio Inc. Director Stock Option (Right to Buy) 53.5K $17.7K $13.42 Oct 23, 2025 Direct
Merus N.V. President, CEO & PEO, Director Common Shares 0 $0 $95.06 Nov 25, 2025 Ante S Lundberg Qualified Annuity Int Trust VII
Merus N.V. President, CEO & PEO, Director Common Shares 0 $0 $95.06 Nov 25, 2025 Ante Sven Lundberg Qualified Annuity Interest Trust IX
Merus N.V. President, CEO & PEO, Director Common Shares 0 $0 $95.06 Nov 25, 2025 Ante Sven Lundberg Qualified Annuity Interest Trust VI
Merus N.V. President, CEO & PEO, Director Common Shares 0 $0 $95.06 Nov 25, 2025 Ante Sven Lundberg Qualified Annuity Interest Trust VIII
Merus N.V. President, CEO & PEO, Director Common Shares 0 $0 $95.06 Nov 25, 2025 Direct
Vor Biopharma Inc. Director Stock Option (Right to Buy) 30K May 22, 2025 Direct

Insider Reports Filed by Sven Ante Lundberg

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MRUS Merus N.V. Nov 25, 2025 11 $0 4 Nov 28, 2025 President, CEO & PEO, Director
QTTB Q32 Bio Inc. Oct 23, 2025 1 $0 4 Oct 27, 2025 Director
VOR Vor Biopharma Inc. May 22, 2025 1 $0 4 May 23, 2025 Director
MRUS Merus N.V. Apr 17, 2025 4 $0 4 Apr 21, 2025 President, CEO & PEO, Director
MRUS Merus N.V. Feb 19, 2025 2 $0 4 Feb 21, 2025 President, CEO & PEO, Director
MRUS Merus N.V. Feb 13, 2025 2 $400K 4 Feb 18, 2025 President, CEO & PEO, Director
MRUS Merus N.V. Jan 29, 2025 1 $0 4 Jan 31, 2025 President, CEO & PEO, Director
QTTB Q32 Bio Inc. Jan 15, 2025 12 $0 4 Feb 26, 2025 Director
QTTB Q32 Bio Inc. Sep 25, 2024 1 $0 4 Sep 27, 2024 Director
VOR Vor Biopharma Inc. May 23, 2024 1 $0 4 May 28, 2024 Director
MRUS Merus N.V. May 7, 2024 1 $0 4 May 9, 2024 President, CEO & PEO, Director
QTTB Homology Medicines, Inc. Mar 25, 2024 1 $0 4 Mar 27, 2024 Director
QTTB Homology Medicines, Inc. Mar 25, 2024 0 $0 3 Mar 27, 2024 Director
VOR Vor Biopharma Inc. May 26, 2023 1 $0 4 Jun 2, 2023 Director
MRUS Merus N.V. Feb 2, 2023 1 $0 4 Feb 3, 2023 President, CEO & PFO, Director
MRUS Merus N.V. Nov 3, 2022 1 $211K 4 Nov 3, 2022 President, CEO & PFO, Director
MRUS Merus N.V. Aug 22, 2022 0 $0 4/A Oct 24, 2022 President, CEO & PFO, Director
MRUS Merus N.V. Aug 19, 2022 1 $16.2K 4 Aug 22, 2022 President, CEO & PFO, Director
MRUS Merus N.V. Jul 12, 2022 1 $99.7K 4 Jul 13, 2022 President, CEO & PFO, Director
VOR Vor Biopharma Inc. Jun 14, 2022 1 $0 4 Jun 16, 2022 Director
MRUS Merus N.V. Jan 31, 2022 1 $0 4 Feb 2, 2022 President, CEO & PFO, Director
MRUS Merus N.V. Aug 2, 2021 4 $0 4 Aug 4, 2021 President, CEO & PFO, Director